Professional Documents
Culture Documents
FINAL MODULE Edited
FINAL MODULE Edited
a. Oxygen
b.Carbon dioxide
c. Vitamin C
d.Vitamin B - 12 and folic acid *****
_________________________________________
4- Stage II Non – Hodgkin’s lymphoma is :
a. Acute leukemias
b. Primery myelofibrosis
c. Iron deficiency anemia***
d. Megaloblastic anemia
_________________________________________
6- What may be felt in the nech or under the
arms in aperson with non - hodgkins lymphoma ?
a. Lymphocyte rich
b. Follicular****
c. Nodular sclerosis
d. Mixed cellularity
_________________________________________
8- In the breakdown of RBC bilirubin is :
a. Oxidized to bilverdin
b. Excreted****
c. Returned to the pool
d. Reused by new red cell
_________________________________________
9- Stage IV Non - hodgkins lymphopma is :
a. In the colon
b. In the limbic system
c. In the alimentary canal
d. In the lymphatic system****
_________________________________________
11- Stage Ill Non - hodgkins lymphopma is:
a. Severe rages
b. Liver cancer
c. Stomach cancer
d. Mental confusion and dementia***
_________________________________________
25- Isoimmune hemolytic anemia is caused by:
a. B-lineage immunophenotype****
b. CNS involvement
c. Age ˂ 1
d. A WBC ˃ 20,000
_________________________________________
28- Primary lymphoid organs are:
a. Thymus gland
b. Bone marrow
c. Both****
d. None of them
_________________________________________
29- A 60-year-old man presents with headaches
and anaemia . Investigations reveal an IgM
paraprotein of 30 g/L . What is the most likely
diagnosis?
a. Waldenstrem macroglobilinemia****
b. Mycosis fungoides
c. Follicular lymphoma
d. Burkitt’s lymphoma
_________________________________________
30- Erythropoietin is secreted by:
a. Bone marrow
b. Hupophysis
c. Kidney****
d. Adrenal gland
_________________________________________
31- Granulocytes are all except:
a. Basophill
b. Platelet***
c. Eosinophill
d. Segmented Neurophils
_________________________________________
32- Which of the following is a bad prognostic
indicator in acute myeloid leukemia :
a. Normal cytogenetics
b. ˃3 clonal chromosomal abnormalities***
c. Rapid response to therapy
d. No CNS involvement
_________________________________________
33- Mature B cells are:
a. Plasma cell****
b. Cd4+ lymphocyte
c. Mast cell
d. Cd8+ lymphocyte
_________________________________________
34- Tear-drop shaped erythrocytes are
characterstics for:
a. Primary Myelofibrosis****
b. Thalassemia
c. Multiple Myeloma
d. Hodgkin’s Lymphoma
_________________________________________
35- Hiatus Leukemicus is typical for :
a. Multiple myeloma
b. Chronic Leukemias
c. Myeloprolypherative disorders
d. Acute leukemias***
_________________________________________
36- What the WBC (leukocytes) indicates :
a. Autoimmune disorders
b. Myelodysplastic syndrome
c. Acute viral infections***
d. Immune deficiency
_________________________________________
43- Non-Hodgkin lymphoma:
a. Mixed cellularity
b. Lymphocyte rich
c. Follicular****
d. Nodular sclerosis
_________________________________________
44- In warm antibody haemolytic anemia
antibodies are mostly:
a. Ig E
b. Ig G****
c. Ig D
d. Ig M
_________________________________________
45- The hemoglobin types found in a normal
adult are:
a. A , A2 ; F****
b. A2 , F
c. A , A2 , C
d. S , A , F
_________________________________________
46- Stage I Non - hodgkins lymphopma is :
A. Lymph nodes
B. Spleen
C. All above
D. Lymphoid tissues
_________________________________________
48- Mature T cells marker is :
A. CD20.
B. CD117.
C. CD4.
D. CD30.
_________________________________________
_________________________________________
_________________________________________
_________________________________________
_________________________________________
LABORTATORY MEDICINE
A. 4.89 mmol/L;
B. 5.1 mmol/L;
C. 3,5;
D. ≥ 6.1mmol/L;
_________________________________________
2- Urea is a waste product formed in
A. muscles
B. liver
C. heart
D. Kidneys
_________________________________________
_________________________________________
_________________________________________
_________________________________________
_________________________________________
ONCOLOGY
1- Which of the following are good prognostic
factors in breast cancer?
a. HER 2 receptor overexpression
b. Grade III tumour
c. Lymph node involvement
d. Oestrogen receptor positivity
_________________________________________
2- Which one of the following best describe
follicular carcinoma of the thyroid ?
a. High risk spread to liver
b. Associated with poor prognosis
c. Best treated with surgery and radioisotope
therapy
d. Rapidly growing
_________________________________________
3- a 45 years old man has a positive stool guaiac
test during a routine physical examination. A
colonoscopy is performed and a 0.9 cm
circumscribed,pedunculated mass on a short
stalk is found in the upper rectum. Which of the
following terms best describes this lesion?
select one
A. Hamartoma.
B. Adenoma.
C. Choristroma.
D. Hyperplasia.
_________________________________________
4- Which of the following is associated with the
highest risk of breast cancer?
A. Nulipanty
B. Dense breasts on mammogram
C. Postmenopausal estrogen plus progestin
therapy
D. Postmenopausal obesity
_________________________________________
5- A 53-year-old woman presents with a palpable
mass in the upper outer quadrant of her left
breast. Breast imaging confirms the presence of
a 2.0-cm mass, and a core needle biopsy finds
invasive ductal carcinoma, grade 3, ER < 5%, PR <
5%, HER2 IHC 0. She proceeded with breast
conserving surgery and a sentinel lymph node
biopsy. Pathology showed a 2.2-cm invasive
cancer with negative margins. A total of two
sentinel lymph nodes were recovered, one of
which contained a 0.8-cm macrometastasis.
Adjuvant chemotherapy and radiotherapy are
planned. What is the preferred next step in
locoregional management?
Select one:
A. Completion axillary lymph node
dissection
B. Completion mastectomy with axillary
lymph node dissection
C.Completion mastectomy
D. No further axillary surgery
E. Ultrasound of the axilla to evaluate for
residual disease
6- in cancer of the ovary which of the following is
true?
A. The level of CEA is used to monitor
response
B. Teratomas are usually malignant
C.Common types are cystic
D. The common histology is a squamous
carcinoma
E. Blood-borne spread is an early feature
_________________________________________
7- Which of the following statements is/are
CORRECT regarding molecular abnormalities
observed in lung cancer?
A. C-Kit expression is seen in most NSCLCS
B. Chromosome 3p allele foss is one the
most common events in lung cancer
pathogenesis
C.all given options are correct
D. Chromosomal translocations have not
been seen in NSCLC
_________________________________________
8- Which of the following statements is correct
regarding pulmonary carcinoid tumors?
A. Adjuvant chemotherapy is the standard
of care following complete surgical resection
B. Surgery has a curative potential for
resectable localized tumors.
C. Most pulmonary carcinoids are atypical
carcinoids
D. Patients usually present with carcinoid
syndrome.
_________________________________________
9- Which of the following is true of cancer of the
cervix?
A. Surface ulceration is common
B. Lymph node spread is rare
C.The common form is an adenocarcinoma
D. The usual path of spread is into the
uterine cavity
E. Squamous cancers typically arise from the
endocervical canal
_________________________________________
10- A 55-year-old man with a 30 pack-year
history of smoking, presents to the emergency
room with shortness of breath. Chest radiograph
demonstrates a right upper lobe opacity.
Computed tomography scan reveals a 3.5-cm
spiculated mass in the peripheral right upper
lobe, which is suspicious for malignancy, without
any hilar or mediastinal lymphadenopathy. What
is the next best step in management?
A. Brain MRI
B. Refer to thoracic surgeon for resection.
C. CT-guided biopsy of the mass
D. Bronchoscopy and biopsy of the mass
_________________________________________
11- Which of the following parts of pancreas is
most common site for cancers?
A. Head of pancreas
B. Body of pancreas
C. Tail of pancreas
D. Diffuse
_________________________________________
12- Which three of the following are true in the
treatment of endometrial cancer?
A. Hormone replacement therapy should be
encouraged after treatment
B. Radiotherapy is not useful as the cancer
is radioresistant
C.Advanced disease may respond to
antioestrogen therapy
D. Most cases are cured after radical
hysterectomy
E. Chemotherapy is effective for advanced
disease
_________________________________________
13- Which of the following increases the risk of a
woman developing ovarian cancer?
A. Nulliparity
B. Use of oral contraceptives for >5
consecutive years
C. Tubal ligation
D. Breastfeeding
_________________________________________
13- CA-125 is most useful in what aspect of
ovarian cancer management?
A. Screening
B. Monitoring treatment
C. Diagnosis
D. Prediction of metastasis
_________________________________________
14- Characteristic features of BRCA1-associated
breast cancers include the following except
Select one
A. Young age at presentation
B. Estrogen receptor (ER) positive
C. Aggressive features
D. HER 2 negative
_________________________________________
15- A 28-year-old woman presented to her
primary care doctor with a right breast mass that
persisted through three menstrual cycles. A
mammogram was not interpretable due to dense
breast tissue, and an ultrasound showed a 2.5-
cm breast mass with associated left axillary
lymphadenopathy. A core biopsy of the breast
mass was obtained, showing invasive ductal
carcinoma, grade 3, ER/PR negative, HER2 2+ by
immunohistochemistry, with a FISH ratio of 4.3
and a HER2 copy number of 9.5. She reports a
family history of breast cancer in a paternal aunt
at age 35, a history of a brain tumor in that
aunt's child at age 10, and a history of a bone
cancer in a paternal grandmother. She is referred
for genetic testing. What is the most likely
genetic abnormality identified?
Select one:
A. PALB2 mutation
B. BRCA2 mutation
C. P53 mutation
D. APC mutation
_________________________________________
50- Bevacizumab:
A) Is a monoclonal antibody that targets
vascular endothelial growth factor (VEGF).
B) Is a monoclonal antibody that targets
epidermal growth factor receptor (EGFR).
C) Has no proven survival benefit in the
metastatic setting.
D) Is standard treatment for metastatic
colorectal cancer in UK.
_________________________________________
51- regarding metastasis from colorectal cancer
and symptomatic management of them:
A) Liver metastasis are a rare feature.
B) Hyperproteinemia is common.
C) Liver capsular pain usually responds well
to non-steroidal anti-inflammatory drugs.
D) Cerebral metastasis are common.
52- acute bowel obstruction in advanced
colorectal cancer:
A) Is usually managed by surgery.
B) Is usually caused by obstruction at a single
site in the bowel.
C) Should be treated with regular oral anti-
emetics, analgesics and antispasmodics.
D) Should be treated with using a syringe
driver containing a mixture of anti-emetics,
analgesics and anti-spasmodics.